- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 40/32 - T-cell receptors [TCR]
Patent holdings for IPC class A61K 40/32
Total number of patents in this class: 117
10-year publication summary
|
0
|
0
|
0
|
1
|
11
|
8
|
6
|
1
|
1
|
63
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Fred Hutchinson Cancer Center | 440 |
8 |
| Medigene Immunotherapies GmbH | 72 |
7 |
| The Regents of the University of California | 19868 |
5 |
| Board of Regents, The University of Texas System | 5772 |
3 |
| The Trustees of the University of Pennsylvania | 4314 |
3 |
| Oslo Universitetssykehus HF | 188 |
3 |
| Immatics US, Inc. | 62 |
3 |
| Adaptimmune Limited | 188 |
2 |
| Benaroya Research Institute at Virginia Mason | 38 |
2 |
| Immatics Biotechnologies GmbH | 1156 |
2 |
| Institut Curie | 582 |
2 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 2804 |
2 |
| Kite Pharma, Inc. | 411 |
2 |
| Seattle Children's Hospital (dba Seattle Children's Research Institute) | 183 |
2 |
| The United States of America,as represented by the Secretary, Department of Health and Human Service | 115 |
2 |
| Lyell Immunopharma, Inc. | 78 |
2 |
| Mnemo Therapeutics | 33 |
2 |
| Abata Therapeutics, Inc. | 13 |
2 |
| CERo Therapeutics Holdings Inc | 13 |
2 |
| Genentech, Inc. | 3975 |
1 |
| Other owners | 60 |